VALEANT PHARMACEUTICALS INTERNATIONAL

Valeant Pharmaceuticals International, Inc., (NYSE: VRX) was trading -46.83% away from its yearly high level, during the last trading session.

Valeant Pharmaceuticals International, Inc., (NYSE: VRX) was trading -44.90% away from its yearly high level, during the last trading session.

Valeant Pharmaceuticals International, Inc., (NYSE: VRX) was trading -43.09% away from its yearly high level, during the last trading session.

Valeant Pharmaceuticals International, Inc., (NYSE: VRX) was trading -41.19% away from its yearly high level, during the last trading session.

Valeant Pharmaceuticals International, Inc., (NYSE: VRX) was trading -40.49% away from its yearly high level, during the last trading session.

Valeant Pharmaceuticals International, Inc., (NYSE: VRX) was trading -40.66% away from its yearly high level, during the last trading session.

Valeant Pharmaceuticals International, Inc., (NYSE: VRX) was trading -42.22% away from its yearly high level, during the last trading session.

Valeant Pharmaceuticals International, Inc., (NYSE: VRX) was trading -42.76% away from its yearly high level, during the last trading session.